Overview
Hassan Yameen is a Hematologist Oncology provider in Nashua, New Hampshire. Dr. Yameen has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Adult Soft Tissue Sarcoma, Myelofibrosis, EGFR Positive Lung Cancer, and Large-Cell Lung Carcinoma.
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- MANAGED MEDICAID PLAN
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
172 Kinsley St, Nashua, NH 03060
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Inc.
Paul Richardson is a Hematologist Oncology specialist and an Oncologist in Milford, Massachusetts. Dr. Richardson is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Hepatic Venoocclusive Disease with Immunodeficiency, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Graft. Dr. Richardson is currently accepting new patients.
Massachusetts General Physicians Organization Inc
Andrew Yee is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Yee is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Vertebroplasty, and Bone Marrow Aspiration. Dr. Yee is currently accepting new patients.
Pratt Medical Group Inc
Raymond Comenzo is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Comenzo is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Primary Amyloidosis, Multiple Myeloma, Cardiac Amyloidosis, Bone Marrow Transplant, and Tissue Biopsy. Dr. Comenzo is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adult Soft Tissue SarcomaDr. Yameen isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Experienced
- Acute Mountain SicknessDr. Yameen isExperienced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Yameen isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Yameen isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Yameen isExperienced. Learn about Anal Cancer.
- AnemiaDr. Yameen isExperienced. Learn about Anemia.
- AngiosarcomaDr. Yameen isExperienced. Learn about Angiosarcoma.